ES8404686A1 - Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico. - Google Patents

Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico.

Info

Publication number
ES8404686A1
ES8404686A1 ES521359A ES521359A ES8404686A1 ES 8404686 A1 ES8404686 A1 ES 8404686A1 ES 521359 A ES521359 A ES 521359A ES 521359 A ES521359 A ES 521359A ES 8404686 A1 ES8404686 A1 ES 8404686A1
Authority
ES
Spain
Prior art keywords
emesis
dyspepsia
cyproheptadine
carboxylic acid
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521359A
Other languages
English (en)
Other versions
ES521359A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES521359A0 publication Critical patent/ES521359A0/es
Publication of ES8404686A1 publication Critical patent/ES8404686A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS ESTERES DEL ACIDO CIPROHEPTADIN-3-CARBOXILICO Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE X, R, R Y R PUEDEN SER VARIOS TIPOS DE RADICALES.CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), CON UN COMPUESTO DE FORMULA Y-CH2-R, EN LAS QUE Y ES CLORO, BROMO O YODO, Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO INERTE, EN PRESENCIA DE UN ACEPTOR DE ACIDO, TAL COMO UNA BASE ORGANICA FUERTE O UNA BASE INORGANICA, A UNA TEMPERATURAENTRE 5JC Y 100JC.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LA EMESIS.
ES521359A 1982-04-14 1983-04-11 Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico. Expired ES8404686A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/368,257 US4412999A (en) 1982-04-14 1982-04-14 Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds

Publications (2)

Publication Number Publication Date
ES521359A0 ES521359A0 (es) 1984-05-16
ES8404686A1 true ES8404686A1 (es) 1984-05-16

Family

ID=23450498

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521359A Expired ES8404686A1 (es) 1982-04-14 1983-04-11 Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico.

Country Status (16)

Country Link
US (1) US4412999A (es)
EP (1) EP0092114B1 (es)
JP (1) JPS58188879A (es)
KR (1) KR880002042B1 (es)
AT (1) ATE30589T1 (es)
AU (1) AU556530B2 (es)
CA (1) CA1203798A (es)
DE (1) DE3374312D1 (es)
DK (1) DK161983A (es)
ES (1) ES8404686A1 (es)
GR (1) GR78832B (es)
IE (1) IE55033B1 (es)
IL (1) IL68306A (es)
NZ (1) NZ203786A (es)
PT (1) PT76501B (es)
ZA (1) ZA832589B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522821A (en) * 1982-04-14 1985-06-11 Merck & Co., Inc. Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
US4501749A (en) * 1983-10-31 1985-02-26 Merck & Co., Inc. Peripherally selective dopamine antagonists in the treatment of ocular hypertension
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
CA2025398A1 (en) * 1989-09-20 1992-03-15 Timothy Gerard Dinan Diagnosis and treatment of a disorder of the gastrointestinal tract
FR2877573B1 (fr) * 2004-11-05 2007-02-02 Debussy Holding Sa Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
CA2664345A1 (en) 2006-09-29 2008-04-03 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative
WO2014105655A1 (en) 2012-12-24 2014-07-03 Neurogastrx, Inc. Methods for treating gi tract disorders
US9844554B2 (en) 2014-06-24 2017-12-19 Neurogastrx, Inc. Prodrugs of metopimazine
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3014911A (en) * 1958-09-29 1961-12-26 Merck & Co Inc Derivatives of dibenzo[a, e]cycloheptatriene
NL125839C (es) * 1963-12-03
US3981877A (en) * 1972-08-14 1976-09-21 Merck & Co., Inc. Piperidylidene derivatives of carboxy-5H-dibenzo[a,d]cycloheptene
US4072756A (en) * 1973-05-17 1978-02-07 Sandoz Ltd. Tricyclo piperidino ketones and soporific compositions thereof
US4086350A (en) * 1974-11-06 1978-04-25 Smithkline Corporation Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
NL173398C (nl) * 1974-11-11 Merck & Co Inc Werkwijze ter bereiding van farmaceutische preparaten alsmede werkwijze ter bereiding van een aan een benzeenkern gesubstitueerd 1-methyl-4-(10,11-dihydro-5h-dibenzo (a,d)cyclohepten-5-ylideen)-piperidinederivaat.
US4076714A (en) * 1974-11-25 1978-02-28 Merck & Co., Inc. 1-Methyl-4-(2-carboxy-thioxanthen-9-ylidene)-piperidine an appetite stimulant and antihistaminic agent
US4160031A (en) * 1975-03-28 1979-07-03 Merck & Co., Inc. Antihistaminic and appetite stimulating 10,11-dihydro-3-carboxycyproheptadine
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds

Also Published As

Publication number Publication date
CA1203798A (en) 1986-04-29
DK161983D0 (da) 1983-04-13
JPS58188879A (ja) 1983-11-04
PT76501B (en) 1986-02-06
GR78832B (es) 1984-10-02
DK161983A (da) 1983-10-15
IL68306A0 (en) 1983-07-31
EP0092114B1 (en) 1987-11-04
ES521359A0 (es) 1984-05-16
EP0092114A3 (en) 1985-01-16
EP0092114A2 (en) 1983-10-26
ZA832589B (en) 1984-11-28
IE830833L (en) 1983-10-14
DE3374312D1 (en) 1987-12-10
KR880002042B1 (ko) 1988-10-13
ATE30589T1 (de) 1987-11-15
NZ203786A (en) 1985-11-08
KR840004422A (ko) 1984-10-15
IL68306A (en) 1986-09-30
IE55033B1 (en) 1990-05-09
US4412999A (en) 1983-11-01
PT76501A (en) 1983-05-01
AU1318883A (en) 1983-10-20
AU556530B2 (en) 1986-11-06

Similar Documents

Publication Publication Date Title
ES8404686A1 (es) Un procedimiento para la preparacion de compuestos esteres del acido ciproheptadin-3-carboxilico.
PL238469A1 (en) Process for preparing novel derivatives of n-/4-piperidinyl/-benzamide
ES464147A1 (es) Procedimiento de preparacion de derivados de la piperidina.
DK0560604T3 (da) Cinnolin-3-carboxylsyrederivater som 5-HT3 antagonister
EP0184258A3 (en) Novel derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
IL42513A (en) N-(1h-tetrazol-5-yl)-quinaldamide derivatives,their production and pharmaceutical compositions containing them
GB1459943A (en) Heterocyclic esters of alkylphenyl benzopyrans
ES374291A1 (es) Un procedimiento para la preparacion de compuestos de 6,7- diaciloxi-tetrahidroisoquinoleinas.
DK447387A (da) Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DE1620652A1 (de) Verfahren zur Herstellung von Indolverbindungen
ES8500238A1 (es) "procedimiento de preparar compuestos 1(2h)-isoquinolonicos y similares".
JPS5793994A (en) Novel glucosamine derivative, its preparation, and remedy for peptic ulcer containing the same
Nakane et al. Effects of biogenic monoamines and precursors on stress ulcers and secretion in stomach
GB900352A (en) Dextro- and laevo-rotatory 5-(3-dimethylamino-2-methylpropyl)iminodibenzyl
GB1208129A (en) New imidazole derivatives, process for their production and compositions containing them
GB1119125A (en) New nitrophenyl derivative and pharmaceutical compositions containing the same
SU1220307A1 (ru) Гидробромид 6-карбокси-4,5,6,7-тетрагидроимидазо(4,5-с)пиридина, проявляющий свойства ингибитора синаптосомального захвата гамма-аминомасляной кислоты
RU93044977A (ru) Ароматические производные аминов и способ их получения
JPS51128994A (en) Process for preparing penicillin derivatives
SE7409227L (sv) Amidinokarbamid.
ES8306729A1 (es) "procedimiento de obtencion de 2-isopropil pirido (2-1-b) quinazolinas y sus sales no toxicas con actividad antianafilactica".
DE3362313D1 (en) 4-quinoline derivatives and their preparation
JPS5261224A (en) Succinimide fungicide for gardening
GB1211174A (en) Thienopyridine derivatives
JPS57193477A (en) Pyrimidoquinazoline derivative and its salt, their preparation, and antiallergic agent containing said compounds as active component